The web Browser you are currently using is unsupported, and some features of this site may not work as intended. Please update to a modern browser such as Chrome, Firefox or Edge to experience all features Michigan.gov has to offer.
Naloxone Standing Order - for Pharmacist Use Only
For Michigan pharmacists interested in providing naloxone to Michigan families under the Standing Order, please register by filling out the form below in its entirety.
Naloxone hydrochloride (naloxone) is a medication intended for reversal of opioid overdose in the event of a drug overdose that is the result of consumption or use of one or more opioid- related drugs. This standing order was issued pursuant to Michigan law which allows the chief medical executive to issue a standing order that does not identify particular patients at the time it is issued, for the purpose of a pharmacist dispensing the opioid antagonist naloxone. MCL 333.17701 et seq.
This standing order is intended to ensure that individuals within the State of Michigan who are at risk of experiencing an opioid-related overdose, or who are family members, friends or other persons who are in a position to assist a person at risk of experiencing an opioid-related overdose, are able to obtain naloxone. This order is not intended to be used by organizations who employ or contract with a prescriber who are authorized to write prescriptions. Such organizations should utilize the medical professionals with whom they have a relationship to write prescriptions specific to personnel who would be expected to administer naloxone.
Sample Unsigned Naloxone Standing Order - Note: You must secure a signed copy of the standing order, using the form below, before dispensing Naloxone in Michigan.
List of Pharmacies Approved to Dispense Naloxone
Map: Pharmacies Approved to DIspense Naloxone
Surgeon General's Advisory on Naloxone and Opioid Overdose
Substance Abuse and Mental Health Services Administration (SAMHSA) Naloxone page
CDC: Reverse Overdose to Prevent Death
Note: No prior authorizations for this medication. We do not see patients, nor have any patient data. Patients must go through their primary care provider for all prior authorizations.